This inventor holds 3 USPTO granted patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 1993-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Beerse, BE (1993 - 1994)
- Vosselaar, BE (1996)
Company Filing History:
Years Active: 1993-1996
Title: The Innovative Contributions of Albertus H Van Heertum
Introduction
Albertus H Van Heertum is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of three patents to his name, Van Heertum's work has had a meaningful impact on medical science.
Latest Patents
Van Heertum's latest patents include innovative compounds such as (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-(2- and novel 2,9-disubstituted-4H-pyrido[1,2-a]pyrimidin-4-ones. These compounds are designed to be pharmaceutically acceptable acid addition salts and include stereochemically isomeric forms. His work also encompasses antihypertensive 3-piperidinyl-indazole derivatives, which serve as useful antagonists of neurotransmitters. These pharmaceutical compositions are aimed at treating warm-blooded animals suffering from diseases associated with neurotransmitter release.
Career Highlights
Albertus H Van Heertum is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His career has been marked by a commitment to innovation and the development of effective medical treatments. His patents reflect a deep understanding of medicinal chemistry and a dedication to improving health outcomes.
Collaborations
Throughout his career, Van Heertum has collaborated with esteemed colleagues such as Ludo E Kennis and Jan Vandenberk. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Albertus H Van Heertum's contributions to pharmaceutical innovation are noteworthy. His patents and collaborations demonstrate his commitment to advancing medical science and improving therapeutic options. His work continues to influence the field and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
